In addition to the monetary settlement, Stryker has agreed to establish a committee tasked with preventing violations of the False Claims Act and the Foreign Corrupt Practices Act. The shareholder lawsuit stems from previous legal troubles, including Stryker’s recalled Trident hip implant and alleged illegal cross-labeling promotion of a bone putty product.
More Articles on Orthopedic Devices:
Houston Orthopedic and Spine Hospital Now Has Robotic Spine Surgery
32 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in August
Biomet Announces European Launch of Comprehensive Shoulder Device
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
